Faces of Discovery: Kenny Wilson Pioneers Breakthroughs in Aging and Memory at the Buck Institute

At the Buck, our breakthroughs are powered by people. Faces of Discovery, a new monthly installment to the Buck Blog, introduces the scientists unraveling the mysteries of aging and pioneering ways to help us all live better longer. Kenny Wilson, a scientist whose roots are firmly planted in Novato, California, exemplifies this spirit of discovery. With a distinguished tenure of 13 years at the Buck Institute, Wilson has dedicated his career to understanding the intricate mechanisms of aging, particularly focusing on the poignant decline in cognitive function and memory. His journey from a student grappling with science to a doctoral graduate and postdoctoral fellow at the forefront of aging research highlights a profound passion for unraveling complex biological puzzles and a commitment to improving human longevity and quality of life.

From Curiosity to a Career in Aging Research

Wilson’s fascination with science began not in a pristine laboratory, but in the more hands-on environment of a middle school classroom. "Most subjects in school teach you facts and expect you to memorize them," Wilson reflects. "Science is only partially about learning facts, because a huge part of it is finding things out for yourself!" This fundamental principle, nurtured by an encouraging science teacher who championed experimentation, ignited a lifelong pursuit of knowledge. By high school, the burgeoning field of genetics and the ambitious Human Genome Project had solidified his trajectory. He pursued a degree in molecular and cell biology from the University of California, Berkeley, a foundational step that paved the way for his doctoral studies.

The decision to pursue his PhD at the Buck Institute was a deliberate one, drawn by its proximity to his hometown of Novato and its stellar reputation in aging research. He completed his Master’s degree through Dominican University in 2014 and went on to earn his PhD in the Biology of Aging from the Buck Institute – University of Southern California joint program in 2019, working under the guidance of Dr. Pankaj Kapahi. This period of intensive study and research culminated in a postdoctoral fellowship in the laboratory of Dr. Lisa Ellerby. His dedication and significant contributions to the field have now earned him a faculty position in the Department of Neurology at the Ohio State University Wexner Medical Center, a testament to his expertise and the impact of his work.

Unraveling the Mysteries of Age-Related Memory Loss

Wilson’s research is driven by a deep-seated desire to understand and combat one of the most distressing aspects of aging: the erosion of memory. "One of the saddest parts of aging is when a person cannot remember their favorite past experiences or their loved one, and I want to understand why that happens," he states. This personal connection fuels his scientific inquiry, particularly his focus on Alzheimer’s disease, a prevalent and emotionally devastating condition linked to brain aging.

"The biggest problem is that while we know what happens in Alzheimer’s, we don’t necessarily know how it happens or what we can do about it," Wilson explains. His work aims to bridge this critical knowledge gap, seeking to elucidate the fundamental cellular and molecular processes that lead to cognitive decline.

A Glimpse into Cellular Mechanisms: Protein Transport and Neural Protection

At the core of Wilson’s research is the intricate process of protein movement within neurons, the vital brain cells responsible for forming and processing memories. He explains, "Some of the cells in your brain are very unique, since they need to perform the specialized function of regularly and rapidly communicating to form memories and thoughts. These cells do this by sending ‘cargo’ to each other through electrical impulses." As the body ages, this essential cellular trafficking system can falter, leading to a breakdown in cognitive function.

Wilson’s groundbreaking work has identified a specific gene that plays a crucial role in enhancing this protein transport mechanism as we age. "When we make this process more efficient, it actually protects lots of different parts of the neurons, including your DNA," he reveals. This finding is particularly significant given the observed DNA damage in Alzheimer’s disease. By bolstering the efficiency of protein trafficking, Wilson’s research offers a potential cellular target for interventions aimed at preventing or treating age-related neurological disorders.

This research, detailed in his doctoral work and subsequent postdoctoral studies, represents a significant step forward in understanding the cellular underpinnings of memory. The ability to maintain efficient protein transport within neurons could hold the key to preserving cognitive function throughout a person’s lifespan.

The Broader Implications: Towards Therapies for Cognitive Health

The ultimate goal of Wilson’s research is to preserve brain function for everyone as they age. "The goal of my work is to preserve everyone’s brain function with age," he asserts. He believes that the cellular mechanisms he has identified can serve as a therapeutic target. The subsequent phase of this research will involve exploring how to best leverage these targets to develop effective treatments for individuals experiencing age-related cognitive decline. This endeavor holds the promise of ensuring that people can retain their thoughts and memories throughout their lives, significantly enhancing their quality of life and independence.

The implications of this research extend far beyond the laboratory. By identifying ways to protect neuronal function and combat the cellular breakdown associated with aging, Wilson’s work contributes to a growing body of evidence suggesting that healthy aging is an achievable goal. The potential for developing therapies that slow or even reverse age-related cognitive decline could revolutionize geriatric care and significantly reduce the societal burden of neurodegenerative diseases.

The Future of Aging Research: Technology as a Catalyst for Discovery

Looking ahead, Wilson is particularly enthusiastic about the accelerating pace of technological innovation in the field of aging research. "One exciting thing about the current state of science is that there are constantly new technologies that make research faster and easier," he notes. He highlights the transformative role of artificial intelligence (AI) in identifying subtle patterns in cellular health that might elude human observation. AI algorithms can now distinguish between healthy cells and those exhibiting age-related disease markers with remarkable speed and accuracy.

Furthermore, automation technology is dramatically accelerating the drug discovery process. While previously it might have taken weeks to test the effects of a single compound on cellular function, robotics now enable the simultaneous testing of thousands of drugs. This technological leap promises to expedite the identification of novel and effective medicines for age-related conditions.

The synergy between advancements in AI, automation, and molecular biology is creating an unprecedented era of discovery in aging research. Wilson’s own journey, from a middle school student’s curiosity to a leading researcher, is a testament to the power of persistent inquiry and the transformative potential of scientific exploration. As he transitions to his new role at Ohio State University, his foundational work at the Buck Institute will undoubtedly continue to inspire and inform future breakthroughs in our quest for healthier, longer lives. The Buck Institute, with its commitment to fostering such talent, remains a beacon for those dedicated to unraveling the complexities of aging and pioneering solutions for a healthier future.